Streetbeat News

Stock Prices

CRSP

Over the past 3 months, 13 analysts have published their opinion on CRISPR Therapeutics (NASDAQ:CRSP) stock. The average price target for the stock is $68.46, with a high of $88.00 and a low of $42.00. The average price target has increased by 8.67% over the past month.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 1:00 pm

BLTE

Over the past 3 months, 4 analysts have published bullish opinions on Belite Bio (NASDAQ:BLTE) stock. The average price target is $56.0, implying significant upside from the current price of $18.2. However, this average has decreased by 3.45% from the previous average price target of $58.00.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 1:00 pm

SPY

The S&P/CS HPI Composite - 20 n.s.a. (YoY) for May has reported a 1.7% increase, beating the estimated -2.2% and the prior -1.7%.

Portfolio Pulse from Happy Mohamed

July 25, 2023 | 1:00 pm

COST

Over the past 3 months, 17 analysts have published their opinion on Costco Wholesale (NASDAQ:COST) stock. The average price target is $556.71, implying a downside from the current price of $563.93. The current average has increased by 2.15% from the previous average price target of $545.00.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 1:00 pm

DIS

Over the past 3 months, 16 analysts have published their opinion on Walt Disney (NYSE:DIS) stock. The average price target for Disney is $115.88, a decrease of 7.24% from the previous average price target of $124.93. The majority of the analysts are bullish on the stock.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 1:00 pm

INPX

Trading of Inpixon (INPX) shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:56 pm

GLW

Corning Inc's shares are trading lower following mixed Q2 results and weak Q3 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 12:51 pm

DOV

Dover Corp (NYSE:DOV) reported a Q2 2023 revenue decline of 3% Y/Y to $2.10 billion, missing the consensus of $2.20 billion. Adjusted EPS declined 4% Y/Y to $2.05, also missing the consensus of $2.20. The company's ERP system upgrade disrupted manufacturing and shipment, reducing revenue and EPS. Dover revised its 2023 guidance, expecting adjusted EPS of $8.85-$9.00 and revenue growth of 2%-4%. DOV shares are trading lower by 3.35% premarket.

Portfolio Pulse from Lekha Gupta

July 25, 2023 | 12:48 pm

GOOGL

Alphabet Inc. (NASDAQ:GOOGL) is expected to report higher Q2 earnings at $1.34 per share, up from $1.21 per share a year ago, with revenues of $72.8 billion. The company's shares rose 1.3% to close at $121.53 on Monday. Several analysts have recently updated their price targets for Alphabet, with the highest target set at $150 by Jefferies analyst Brent Thill.

Portfolio Pulse from Lisa Levin

July 25, 2023 | 12:41 pm

COSM

ETST

RCG

Insiders at Earth Science Tech, Inc. (OTC:ETST), Cosmos Health Inc. (NASDAQ:COSM), and RENN Fund, Inc. (NYSE:RCG) have recently made notable purchases of their companies' shares. This could indicate their confidence in the companies' prospects. Earth Science Tech recently appointed a new CFO, Cosmos Health priced a $5.25 million registered direct offering and concurrent private placement, and RENN Fund has a 52-week high of $2.39.

Portfolio Pulse from Lisa Levin

July 25, 2023 | 12:41 pm